Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/20/2014US20140079679 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
03/20/2014US20140079671 Antibacterial Phage, Phage Peptides And Methods Of Use Thereof
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/20/2014US20140079664 Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
03/19/2014EP2708603A1 Diagnostic and therapeutic uses of gelsolin in renal failure
03/19/2014EP2708561A2 Bio-pin
03/19/2014EP2708554A1 Insulin analogues with an acyl and alkylene glycol moiety
03/19/2014EP2708551A1 Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
03/19/2014EP2708549A2 Improved vaccines and methods for using the same
03/19/2014EP2708236A1 Tumor treatment
03/19/2014EP2708235A1 Peptide antagonists of the vasopressin-2 receptor
03/19/2014EP2708234A1 Tetraspanin CD82 as a diagnostic and/or therapeutic module for xenograft recognition and/or rejection
03/19/2014EP2708233A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
03/19/2014EP2707394A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
03/19/2014EP2707384A1 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
03/19/2014EP2707019A1 Wound debridement compositions containing seaprose and methods of wound treatment using same
03/19/2014EP2707018A1 Methods and pharmaceutical compositions for the treatment of autoimmune diseases
03/19/2014EP2707017A1 Lixisenatide and metformin for treatment of diabetes type 2
03/19/2014EP2707016A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
03/19/2014EP2707015A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
03/19/2014EP2707014A1 High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain
03/19/2014EP2707013A1 Cns antigen-specific b cell, t cell and antibody assays and their uses in diagnosis and treatment of multiple sclerosis
03/19/2014EP2707009A1 Antipyretics to enhance tolerability of vesicle-based vaccines
03/19/2014EP2707005A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
03/19/2014EP2706991A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
03/19/2014EP2706976A1 Novel anti-redness active agent and cosmetic compositions comprising same
03/19/2014CN1938046B Monomethylvaline compounds capable of conjugation to ligands
03/19/2014CN103649326A Antibody-like proteins for therapeutic and diagnostic use
03/19/2014CN103649127A Compositions, uses and methods for treatment of metabolic disorders and diseases
03/19/2014CN103649113A Targeting deregulated WNT signaling in cancer using stabilized alpha-helices of BCL-9
03/19/2014CN103649108A A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
03/19/2014CN103649107A Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
03/19/2014CN103649106A Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
03/19/2014CN103648531A Method for prevention or treatment of metabolic syndrome
03/19/2014CN103648522A Treatment of microbial infections
03/19/2014CN103648521A Intravascular delivery of nanoparticle compositions and uses thereof
03/19/2014CN103648520A Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
03/19/2014CN103648519A Pharmaceutical combination for use in the treatment of diabetes type 2 patients
03/19/2014CN103648518A Combination therapy for ischemia
03/19/2014CN103648517A Neuroprotective peptides
03/19/2014CN103648516A Treatment of hepatitis c virus infection with alisporivir
03/19/2014CN103648515A BPI and its congeners as radiation mitigators and radiation protectors
03/19/2014CN103648513A Yeast-brachyury immunotherapeutic compositions
03/19/2014CN103648509A Methods and compositions relating to mesenchymal stem cell exosomes
03/19/2014CN103648508A Viral inactivated platelet extract, use and preparation thereof
03/19/2014CN103648491A Methods and pharmaceutical compositions for inhibiting influenza viruses replication
03/19/2014CN103648489A Multiple antigen presenting immunogenic composition, and methods and uses thereof
03/19/2014CN103642898A Mutations in oas1 genes
03/19/2014CN103642882A Process for producing dipeptides
03/19/2014CN103642816A Chlamys farreri scavenger receptor cys-rich (CfSRCR)-2 gene for prokaryotic recombinant expression and preparation and application thereof
03/19/2014CN103642812A Nile tilapia apoptosis factor FasL gene and applications thereof
03/19/2014CN103641918A OX40/TRAIL fusion proteins
03/19/2014CN103641911A Araneus ventricosus serine protease inhibitor AvSPI gene and encoding protein and application thereof
03/19/2014CN103641907A Glucagon/glp-1 receptor co-agonists
03/19/2014CN103641906A Glucose-dependent insulinotropic polypeptide analogues
03/19/2014CN103641905A Interferon alpha1b mutant and fusion protein containing interferon alpha1b and human serum albumin
03/19/2014CN103641904A Engineering bacterium capable of producing human selenoprotein P mutant and application thereof
03/19/2014CN103641903A Bullfrog antimicrobial peptide CRC, and modified body, coding nucleic acid and application thereof
03/19/2014CN103641902A Polypeptide valid target in Ropalidia fasciata insects and application thereof in preventing and treating cerebral thrombosis
03/19/2014CN103641899A Isatis root vegetable proteins or polypeptides, extraction method thereof, and application thereof in antiviral drug
03/19/2014CN103641892A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/19/2014CN103641889A Hypoglycemic peptide and drug use thereof
03/19/2014CN103641888A Multifunctional novel small peptide, composition including same and application of small peptide
03/19/2014CN103641885A Protein purification by ion exchange chromatography
03/19/2014CN103638527A Hemopoietin drug-carried nanoparticles and application thereof
03/19/2014CN103638516A Medicinal composition containing urate oxidase and preparation method thereof
03/19/2014CN103638515A Anti gram-positive bacterium composition of anglerfish skin collagen peptide
03/19/2014CN103638514A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/19/2014CN103637979A Pidotimod oral liquid
03/19/2014CN103637978A Stable gel containing bromelain
03/19/2014CN103637192A Anti-aging health food and its preparation method
03/19/2014CN102977215B Caspase-1 inhibitor targeting liver and application thereof
03/19/2014CN102911264B Platelet aggregation inhibitor composition
03/19/2014CN102885782B Growth hormone-containing nanometer medicament microspheres and preparation method thereof
03/19/2014CN102861360B Neural restoration promoting material as well as preparation method and application thereof
03/19/2014CN102786583B Rana kunyuensis modified antibacterial peptides as well as preparation method and application of rana kunyuensis kunyuenin kunyuenin-3
03/19/2014CN102764423B Polypeptide drug composition obtained through hydrolysis of animal livers and preparation method thereof
03/19/2014CN102727893B Recombinant human endostatin liposome microbubble and application thereof in preparing medicament for inhibiting tumor angiogenesis under ultrasound mediation
03/19/2014CN102676621B Antihypertensive rapeseed peptide and preparation method and application of antihypertensive rapeseed peptide
03/19/2014CN102552145B Preparation method of artificial liposome
03/19/2014CN102488892B Composite propolis composition used for treating unknown swine high-fever, and preparation method thereof
03/19/2014CN102430115B Compound propolis composition for treating porcine circovirus disease and preparation method thereof
03/19/2014CN102199215B MAPWA fusion antibacterial peptide, preparation method and application thereof
03/19/2014CN101815526B Peptide sequences and compositions
03/19/2014CN101657212B Methods of use of TRK receptor modulators
03/19/2014CN101578107B Oxyntomodulin analogue and their effects on feeding behavior
03/18/2014USRE44812 Method for extracting hydrophobin from a solution
03/18/2014US8674112 Polymorph of a pharmaceutical
03/18/2014US8674085 2′-branched nucleosides and Flaviviridae mutation
03/18/2014US8674077 Processes for producing silk dope
03/18/2014US8674076 BSL2vcvc-lg polypeptides
03/18/2014US8674075 Chimeric peptides for the regulation of GTPases
03/18/2014US8674072 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
03/18/2014US8674070 Cancer-targeting peptides and uses thereof in cancer therapy
03/18/2014US8674069 MELK epitope peptides and vaccines containing the same
03/18/2014US8674064 Immunogenic compositions against human progastrin peptides
03/18/2014US8674060 Peptide ligand to impair cancer cell migration
03/18/2014US8674059 Colon cancer related gene TOM34
03/18/2014US8674020 Process for preparing polyamides
03/18/2014US8673972 Human papilloma virus as predictor of cancer prognosis
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 3163